Trial Profile
A Phase III trial of tesetaxel in patients with metastatic breast cancer
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 05 Aug 2021
Price :
$35
*
At a glance
- Drugs Tesetaxel (Primary)
- Indications Breast cancer
- Focus Registrational; Therapeutic Use
- 19 Jun 2012 New trial record